• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Pediatrics

Apgar scores provide prognostic information for survival of preterm infants

byHarsh ShahandDeepti Shroff
July 1, 2020
in Pediatrics
Reading Time: 3 mins read
Quick Take: Analgesic efficacy and safety of morphine in the Procedural Pain in Premature Infants (Poppi) study: randomised placebo-controlled trial
Share on FacebookShare on Twitter

1. Apgar scores at five and ten minutes after birth provided prognostic information for preterm infants regarding neonatal survival.

2. Lower Apgar scores for older gestational age infants were associated with increased neonatal death compared to younger gestational age infants with similar scores.

Evidence Rating Level: 2 (Good)

Study Rundown: Preterm birth is the leading cause of neonatal death. Current policies from the American Academy of Pediatrics do not recommend using the Apgar score to predict neonatal mortality. Moreover, there no specific recommendations for the use of the scoring system in assessing neonatal mortality of preterm infants. As such, this study investigated the association between risk of neonatal death and Apgar scores. Data from the Swedish Medical Birth Register was utilized to investigate the relationship between the risk of neonatal death and Apgar scores at five minutes, the change between five and ten minutes, and at ten minutes in infants stratified by gestational age. The study concluded the Apgar scores at five and ten minutes after birth were associated with neonatal mortality among preterm infants. This retrospective study was limited by the lack of information regarding interventions during initial stabilization of the infants. These life-saving interventions performed within the first five minutes after birth could have influenced Apgar scores and neonatal survival rates. Furthermore, another limitation to the study was the interobserver variability in the Apgar scores. Nonetheless, this study was strengthened by the large cohort of patients and the homogeneity of the study population.

Click to read the study, published today in NEJM

Relevant Reading: Apgar score and the risk of cause-specific infant mortality: a population-based cohort study

RELATED REPORTS

Epidural analgesia in labour is not associated with adverse neonatal health outcomes

Both high and low maternal hemoglobin levels increase neonatal risk

#VisualAbstract: Integrated AI Tool can Accurately Estimate Gestational Age From Blind Ultrasound Sweeps

In-Depth [retrospective cohort]: This retrospective study analyzed the records of 113,300 preterm infants born in Sweden. Patients included in this study were infants born between January 1, 1992 and December 31, 2016. Infants were excluded if they had a birth with a gestational completion age greater than 36 week and 6 days. In collaboration with the Swedish Medical Birth Register, this study was granted access to the medical records of the preterm infants. The medical records contained information on prenatal, delivery, and neonatal care. Preterm birth was defined as an infant born with a gestational age between 22 and 36 weeks. The following information was collected: Apgar scores at five and ten minutes after birth, birth characteristics, and information about maternal pregnancy. The gestational age was determined by the ultrasonography-based Swedish reference curve for normal fetal growth. The primary outcome was neonatal death, defined as death within the first 27 completed days of life. Apgar scores at five and ten minutes after birth were available for 98.1% and 92.1% of all preterm birth, respectively. Neonatal mortality increased with decreasing gestational age from 36 weeks (0.2%) to 22 weeks (76.5%). Similarly, neonatal mortality increased with decreasing Apgar scores. Infants born between 22 to 24 weeks with an Apgar score of 0 or 1 had a higher relative risk of neonatal death compared to infants with a score of 9 or 10 (relative risk, 4.7; 95% confidence interval [CI], 2.7 to 8.3). However, the neonatal mortality relative risk substantially increased with older gestational age and lower Apgar scores (relative risk at 35 or 36 weeks, 313.8; 95% CI, 192.5 to 511.4). Taken together, Apgar scores in the context of gestational age provided prognostic information regarding neonatal survival of preterm infants.

Image: PD

©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: Apgar scoregestational ageneonatal mortalityneonatology
Previous Post

Three-day amoxicillin course effective for chest-indrawing pneumonia in Malawi children

Next Post

Steroids and opioids often inappropriately prescribed in the emergency department for pediatric pneumonia and sinusitis

RelatedReports

Behavioral dysregulation in infancy predicts later child mental health
Imaging and Intervention

Epidural analgesia in labour is not associated with adverse neonatal health outcomes

July 23, 2026
Large proportion of late preterm infants and older admitted to the NICU
Hematology

Both high and low maternal hemoglobin levels increase neonatal risk

February 2, 2026
#VisualAbstract: Integrated AI Tool can Accurately Estimate Gestational Age From Blind Ultrasound Sweeps
StudyGraphics

#VisualAbstract: Integrated AI Tool can Accurately Estimate Gestational Age From Blind Ultrasound Sweeps

August 12, 2024
Racial, ethnic differences in outcomes of extremely preterm infants decreasing but persistent
Emergency

Comparison of different types of ultrasound probes for lung ultrasound in neonates

July 12, 2024
Next Post
Steroids and opioids often inappropriately prescribed in the emergency department for pediatric pneumonia and sinusitis

Steroids and opioids often inappropriately prescribed in the emergency department for pediatric pneumonia and sinusitis

Healthy lifestyle for prevention of premature death among users and nonusers of common preventive medications

#VisualAbstact: Association Between Tumor Necrosis Factor Inhibitor Exposure and Inflammatory Central Nervous System Events

#VisualAbstact: Association Between Tumor Necrosis Factor Inhibitor Exposure and Inflammatory Central Nervous System Events

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Transanastomotic tubes not linked to anastomotic stricture after esophageal atresia repair
  • Artificial intelligence (AI) chatbot reduced depression, anxiety, and eating disorder risk symptoms
  • Real-time AI guidance enters live brain tumor surgery
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.